---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-044125"
form_type: "8-K"
ticker: "QUCY"
cik: "0001874252"
company_name: "Quantum Cyber N.V."
filed_at: "2026-04-15T23:59:59+00:00"
generated_at: "2026-05-15T06:10:32.975996+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Mainz Biomed sells next-gen CRC screening IP for $1.25M, updates Nasdaq equity compliance

## Summary
- Entered asset purchase agreement to sell Next Gen IP for $1.25M; closing by April 23, 2026.
- Proceeds to be used for settlement of outstanding liabilities and general corporate purposes.
- Continues development of pancreatic cancer detection product and explores post-quantum cybersecurity.
- Believes stockholders' equity exceeds $2.5M after receiving $6M total from preferred share sale (Feb & March 2026).
- Previously wound down ColoAlert product and next-gen colorectal cancer screening development in Feb 2026.

## SEC filing metadata
- accession: 0001213900-26-044125
- form_type: 8-K
- ticker: QUCY
- cik: 0001874252
- company_name: Quantum Cyber N.V.
- filed_at: 2026-04-15T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1874252/000121390026044125/0001213900-26-044125-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1874252/000121390026044125/ea0286510-8k_mainz.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-044125
- JSON: https://secwatch.observer/filing/0001213900-26-044125.json
- Plain text: https://secwatch.observer/filing/0001213900-26-044125.txt

## Key facts
- Material Agreements
  Quantum Cyber N.V. entered into Agreement with third-party purchaser incorporated in Italy valued at $1.25 million (effective 2026-04-09).
  - Action: entry
  - Agreement: asset purchase
  - Counterparty: third-party purchaser incorporated in Italy
  - Value: $1.25 million
  - Effective: 2026-04-09
  source text: On April 9, 2026, we entered into an asset purchase agreement (the “Agreement”) for the sale of the Next Gen IP to a third-party purchaser incorporated in Italy. Pursuant to the Agreement, we will sell the Next Gen IP to the buyer for a payment of $1.25 million.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1874252/000121390026044125/0001213900-26-044125-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.